/

Other

/

Averitas Pharma

Averitas Pharma

Averitas Pharma

Verified Nov 2026

Other

·

United States flag

Morristown, New Jersey

·

Since 2018

Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.

Averitas Pharma

Verified Nov 2026

AT A GLANCE

Founded

2018

Headquarters

United States flag

Morristown, New Jersey

Employees

100-200

Ownership

Averitas Pharma at a glance

Revenue

<$10M

Est. band

Employees

100-200

Founded

2018

Headquarters

Morristown, New Jersey

Industries

Automotive

Electric Vehicles

Medical

Overview

Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.

At a glance

Attribute

Detail

Founded

2018

Headquarters

Morristown, New Jersey

Employees

100-200

Revenue

<$10M (estimated)

What Averitas Pharma makes

The company markets an FDA-approved topical analgesic system targeting neuropathic pain conditions and provides clinical and safety information to healthcare providers and patients.

Latest developments

Company details

Averitas Pharma operates within the medical and specialty pharmaceutical sectors, serving patients with chronic pain conditions requiring non-opioid therapeutic options. Averitas Pharma was founded in 2018, has an estimated 100-200 employees, and is headquartered in Morristown, New Jersey.

Frequently asked questions

What does Averitas Pharma do?

Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.

Where is Averitas Pharma headquartered?

Averitas Pharma is headquartered in Morristown, New Jersey (360 Mount Kemble Avenue, Morristown, New Jersey, 07960).

When was Averitas Pharma founded?

Averitas Pharma was founded in 2018.

How big is Averitas Pharma?

Averitas Pharma has an estimated 100-200 employees, with revenue in the <$10M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Morristown, New Jersey (HQ)Headquarters · United States
Morristown, New Jersey (HQ)360 Mount Kemble Avenue, Morristown, New Jersey, 07960, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.